Partners of young breast cancer survivors: a cross-sectional evaluation of psychosocial concerns, coping, and mental health.


Journal

Journal of psychosocial oncology
ISSN: 1540-7586
Titre abrégé: J Psychosoc Oncol
Pays: United States
ID NLM: 8309337

Informations de publication

Date de publication:
Historique:
pubmed: 2 10 2020
medline: 30 6 2021
entrez: 1 10 2020
Statut: ppublish

Résumé

Evaluation of psychosocial concerns, coping style, and mental health in partners of young (diagnosed at ≤40 years) survivors of early-stage breast cancer (BC). Cross-sectional; partners participated in a one-time survey. 289 participants; most were male, white, working full-time, college educated, with median age of 43 years, parenting children <18 years old. Logistic regression was used to explore associations with anxiety and depression (≥8 on Hospital Anxiety and Depression sub-scales). Overall, 41% reported symptoms of anxiety, 18% reported symptoms of depression, and 44% identified maladaptive coping. Multivariable regression analyses revealed: lower social support and poorer quality of life significantly associated with depression ( Partners of young BC survivors who use more maladaptive coping strategies, report less social support, work fulltime, and/or who have lower education levels experience negative mental health outcomes. Enhancing constructive coping and ensuring all partners have access to supportive resources may improve partners' emotional adjustment.

Identifiants

pubmed: 33000705
doi: 10.1080/07347332.2020.1823546
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

670-686

Auteurs

Nancy A Borstelmann (NA)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Shoshana Rosenberg (S)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Shari Gelber (S)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Yue Zheng (Y)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Meghan Meyer (M)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Kathryn J Ruddy (KJ)

Mayo Clinic, Rochester, Minnesota, USA.

Lidia Schapira (L)

Stanford University Medical Center, Stanford, California, USA.

Steven Come (S)

Harvard Medical School, Boston, Massachusetts, USA.
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Virginia Borges (V)

University of Colorado, Aurora, Colorado, USA.

Tamara Cadet (T)

Simmons College School of Social Work, Boston, Massachusetts, USA.

Peter Maramaldi (P)

Simmons College School of Social Work, Boston, Massachusetts, USA.
Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Ann H Partridge (AH)

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH